NCT06503185

Brief Summary

Our team recently closed recruitment for the PREPARE Trial: PReoperative Exercise to decrease PostoperAtive complication Rates and disability scorEs. The trial enrolled a total of 850 participants; 523 of which were recruited locally at The Ottawa Hospital (TOH). Of the 523 enrolled at TOH, 413 patient participants were on the pathway for cancer surgery and have either completed the study or are in follow-up (participants who withdrew from the full study have been excluded from the sample size in this sub-study proposal). Unexpectedly, almost 80% of the PREPARE Trial sample was linked to cancer surgery - most likely because cancer surgeries were prioritized during the pandemic. This provides us with the opportunity, and perhaps the responsibility, to specifically assess oncology related outcomes. We propose to follow this TOH sub-group of oncology patients for five years following their surgical date, by retrospectively collecting clinical and health administrative data at annual timepoints.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
413

participants targeted

Target at P75+ for all trials

Timeline
49mo left

Started May 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
May 2024May 2030

Study Start

First participant enrolled

May 13, 2024

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 16, 2024

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2030

Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

5.1 years

First QC Date

May 28, 2024

Last Update Submit

July 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Event free survival (EFS) in the 5 years after surgery

    Event free survival (similar to disease free survival, but more appropriate for scenarios where surgery is planned after randomization, but could be precluded by disease progression) will be defined using US Food and Drug Administration (FDA) criteria as: the time after randomization to the earliest of a) progression of disease that precludes surgery, local or distant recurrence, or death due to any cause.

    5 years

Secondary Outcomes (2)

  • Patient-reported disability trajectory in the year after surgery measured using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)

    1 year after surgery

  • Return to intended oncologic treatment (RIOT)

    at 4 months after surgery

Other Outcomes (12)

  • Function- Katz Index of Activities of Daily Living

    Day 3, 5, 7 and up to 30 days after surgery

  • Function- Falls

    Day 3, 5, 7 and up to 30 days after surgery

  • Function- Health-related quality of life

    Day 3, 5, 7 and up to 30 days after surgery

  • +9 more other outcomes

Study Arms (2)

Prehabilitation

The intervention is a home-based, multimodal exercise prehabilitation program. Exercise was prescribed in one-hour sessions, performed a minimum of three times per week for three weeks, consisting of: 1) strength training, 2) aerobic exercise and 3) flexibility. The intervention group will receive weekly phone calls to gauge adherence, suggest modifications, provide support and track any adverse events.

Behavioral: Prehabilitation

Control

The control group received the World Health Organization recommendations for physical activity for people greater or equal to the age of 65 years old pamphlet, as well as a guide to healthy eating for older adults.

Interventions

PrehabilitationBEHAVIORAL

The intervention is a home-based, multimodal exercise prehabilitation program. Exercise is prescribed in one-hour sessions, performed a minimum of three times per week for three weeks, consisting of: 1) strength training, 2) aerobic exercise and 3) flexibility. The intervention group will receive weekly phone calls to gauge adherence, suggest modifications, provide support and track any adverse events.

Prehabilitation

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Older adults with frailty having cancer surgery

You may qualify if:

  • Patients aged ≥60 years
  • Scheduled, or on the pathway, for elective surgery eLOS ≥2 days
  • Expected surgery date between 3 and 12 weeks from enrollment
  • Clinical Frailty Scale (CFS) score ≥4/9

You may not qualify if:

  • Inability to speak English or French
  • Co-morbidity preventing assessment or understanding of questionnaires
  • Unable to be contacted by telephone
  • Unwilling to participate in exercise program
  • Cardiac, neurological or orthopedic procedure
  • Palliative surgery
  • Certain cardiovascular conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ottawa Hospital

Ottawa, Ontario, Canada

Location

MeSH Terms

Conditions

NeoplasmsFrailty

Interventions

Preoperative Exercise

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Daniel I McIsaac, MD,MPH,FRCPC

    The Ottawa Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2024

First Posted

July 16, 2024

Study Start

May 13, 2024

Primary Completion (Estimated)

May 31, 2029

Study Completion (Estimated)

May 31, 2030

Last Updated

July 16, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Individual participant data, including data dictionaries, will be available. This includes individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). The Study Protocol, Statistical Analysis Plan and Informed Consent Form will also be made available. Data will be available beginning 3 months and ending 5 years following article publication of one year follow up data. Data will be shared with researchers who provide a methodologically sound proposal. Data can be used to achieve aims in a proposed proposal or for individual participant data meta-analysis. Proposals should be directed to dmcisaac@toh.ca. To gain access, data requestors will need to sign a data access agreement. Data will be shared via an appropriate 3rd party website that is consistent with ethical and health privacy compliant legislation at the time of study conclusion.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available beginning 3 months and ending 5 years following article publication of one year follow up data.
Access Criteria
Data will be shared with researchers who provide a methodologically sound proposal. Data can be used to achieve aims in a proposed proposal or for individual participant data meta-analysis. Proposals should be directed to dmcisaac@toh.ca. To gain access, data requestors will need to sign a data access agreement. Data will be shared via an appropriate 3rd party website that is consistent with ethical and health privacy compliant legislation at the time of study conclusion.

Locations